Literature DB >> 1293383

Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.

R A Coleman1, H S Winter, B Wolf, Y T Chen.   

Abstract

In glycogen storage disease type III (glycogen debranching enzyme (DE) deficiency), the activities of serum alanine aminotransferase, aspartate aminotransferase and lactate dehydrogenase may be strikingly elevated during childhood but are low during adult life. To determine the pattern of the elevated serum enzyme activities in relationship to diet, the biochemical subtype and clinical symptoms, 13 patients with DE deficiency were studied. Activities of serum aspartate and alanine transaminases, lactate dehydrogenase, and alkaline phosphatase were markedly elevated during infancy. Continued elevation of enzyme activities during childhood appeared to be related to DE deficiency in liver, but unrelated to DE deficiency in muscle. Activity elevations correlated inconsistently with diet and poorly with childhood growth rate or the presence of hypoglycaemia. The serum enzyme activities declined around puberty concomitantly with a decrease in liver size. Although periportal fibrosis and micronodular cirrhosis indicated the presence of hepatocellular damage during childhood, the decline in serum enzyme activities with age and the absence of overt hepatic dysfunction suggest that the fibrotic process may not always progress.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293383     DOI: 10.1007/bf01800225

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Optimal rate of enteral glucose administration in children with glycogen storage disease type I.

Authors:  W F Schwenk; M W Haymond
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

2.  Portal diversion for the treatment of glycogen storage disease in humans.

Authors:  T E Starzl; C W Putnam; K A Porter; C G Halgrimson; J Corman; B I Brown; R W Gotlin; D O Rodgerson; H L Greene
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

3.  The subgroups of type 3 glycogenosis.

Authors:  F Van Hoof; H G Hers
Journal:  Eur J Biochem       Date:  1967-10

4.  Type 3 glycogenosis. A family with an unusual tissue distribution of the enzyme lesion.

Authors:  I K Brandt; V A DeLuca
Journal:  Am J Med       Date:  1966-05       Impact factor: 4.965

5.  Type III glycogenosis presenting as liver disease in adults with atypical histological features.

Authors:  I W Fellows; J S Lowe; A L Ogilvie; A Stevens; P J Toghill; M Atkinson
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

6.  Estimation of glucose carbon recycling in children with glycogen storage disease: A 13C NMR study using [U-13C]glucose.

Authors:  B Kalderon; S H Korman; A Gutman; A Lapidot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose.

Authors:  D M Bier; R D Leake; M W Haymond; K J Arnold; L D Gruenke; M A Sperling; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

8.  Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.

Authors:  A E Slonim; C Weisberg; P Benke; O B Evans; I M Burr
Journal:  Ann Neurol       Date:  1982-04       Impact factor: 10.422

9.  Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.

Authors:  J H Ding; T de Barsy; B I Brown; R A Coleman; Y T Chen
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

10.  The ischemic exercise test in normal adults and in patients with weakness and cramps.

Authors:  R A Coleman; J M Stajich; V W Pact; M A Pericak-Vance
Journal:  Muscle Nerve       Date:  1986 Mar-Apr       Impact factor: 3.217

  10 in total
  12 in total

1.  Glycogen storage disease type III in Inuit children.

Authors:  Paul James A Zimakas; Celia J Rodd
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

2.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

3.  Correction of glycogen storage disease type III with rapamycin in a canine model.

Authors:  Haiqing Yi; Elizabeth D Brooks; Beth L Thurberg; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2014-02-08       Impact factor: 4.599

Review 4.  Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?

Authors:  Erin Demo; Donald Frush; Marcia Gottfried; John Koepke; Anne Boney; Deeksha Bali; Y T Chen; Priya S Kishnani
Journal:  J Hepatol       Date:  2006-11-09       Impact factor: 25.083

5.  Skeletal and cardiac muscle involvement in children with glycogen storage disease type III.

Authors:  Engy A Mogahed; Marian Y Girgis; Rodina Sobhy; Hala Elhabashy; Osama M Abdelaziz; Hanaa El-Karaksy
Journal:  Eur J Pediatr       Date:  2015-05-07       Impact factor: 3.183

6.  Markedly elevated serum transaminases in glycogen storage disease type III.

Authors:  Christine Karwowski; Csaba Galambos; David Finegold; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

Review 7.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

8.  Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Authors:  Elizabeth D Brooks; Haiqing Yi; Stephanie L Austin; Beth L Thurberg; Sarah P Young; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

Review 9.  The hepatic glycogen storage diseases--problems beyond childhood.

Authors:  P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

10.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.